Skip to main content
SpringerLink
Log in

Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to identify dosage regimens using intravenous omeprazole and ranitidine that would elevate and consistently maintain intragastric pH>6 in the first 24 hr of therapy. In 19 healthy, fasting human subjects using continuous 24-hr gastric pH-metry, we studied two dosages of primed infusions of ranitidine (50 mg bolus followed by infusion of either 3 or 6 mg/kg body wt/24 hr) and six regimens of intravenous omeprazole (80–200 mg in 24 hr in two to five boluses). Only the two ranitidine infusions and high doses of omeprazole (≥160 mg/day as four or five boluses) raised the intragastric median pH above 5.4. There was no significant difference in the median intragastric pH after high dose ranitidine and high doses of omeprazole. Considerable interindividual variation in intragastric pH was observed after omeprazole therapy. The percentage of intragastric pH>6.0 during the 24-hr study was lower after omeprazole (35–42%) than after high-dose ranitidine (58%). We conclude that it is possible to raise intragastric pH>6.0 by use of either primed ranitidine infusion or by repeated boluses of omeprazole. However, maintenance of this high pH in the first 24 hr is difficult with both, more so with omeprazole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Green FW, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 74:38–43, 1978

    PubMed  Google Scholar 

  2. Chalmhoff C, Creter D, Djaldetti M: The effect of pH on platelet and coagulation factor activities. Am J Surg 136:257–259, 1978

    PubMed  Google Scholar 

  3. Berstad A: Antacids, pepsin inhibitors, and gastric cooling in the management of massive upper gastrointestinal haemorrhage. Scand J Gastroenterol 22(suppl 137):33–38, 1987

    Google Scholar 

  4. Low J, Dodds AJ, Biggs JC: Fibrinolytic activity and gastroduodenal secretions—a possible role in upper gastrointestinal haemorrhage. Thromb Res 17:819–830, 1980

    PubMed  Google Scholar 

  5. Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH: Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: Implications in peptic ulceration. Gut 27:243–248, 1986

    PubMed  Google Scholar 

  6. Patchett SE, Enright H, Afdhal N, O'Connel W, O'Donoghue DP: Clot lysis by gastric juice: Anin vitro study. Gut 30:1704–1747, 1989

    PubMed  Google Scholar 

  7. Collins R, Langman M: Treatment with histamine H2-antagonists in acute upper gastrointestinal hemorrhage. N Engl J Med 313:660–666, 1985

    PubMed  Google Scholar 

  8. Walt RP, Cottrell J, Mann SG, Freemantle NP, Langmann MJS: Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 340:1058–1062, 1992

    PubMed  Google Scholar 

  9. Daneshmend TK, Hawkey CJ, Langman MJS, Logan RFA, Long RG, Walt RP: Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial. Br Med J 304:143–147, 1992

    Google Scholar 

  10. Santucci L, Fiorucci S, Pelli MA, Calderazzo A, Biasini E, Calderazzo PL, Morelli A: Control of gastric pH with ranitidine in critically ill patients. Dig Dis Sci 36:583–587, 1991

    PubMed  Google Scholar 

  11. Marchant J, Summers K, McIsaac RL, Wood JR: A comparison of two ranitidine intravenous infusion regimes in critically ill patients. Aliment Pharmacol Ther 2:55–62, 1988

    PubMed  Google Scholar 

  12. Teyssen S, Scheid J, Fiedler F, Singer MV: Comparison of the effect of two intravenous dosage regimes (dr) of ranitidine (ran) and omeprazole (ome) on 24-hour intragastric (ig) pH in healthy human subjects. Gastroenterology 102:A177, 1992

    Google Scholar 

  13. Teyssen S, Scheid J, Singer MV: Comparison of the effect of intravenous ranitidine, ranitidine and pirenzepine and omeprazole on 24-hour intragastric pH in healthy human subjects. Gastroenterology 104:A210, 1993

    Google Scholar 

  14. Fimmel CJ, Etienne A, Ciluffo T, von Ritter C, Gasser T, Rey JP: Long-term ambulatory gastric pH monitoring: Validation of a new method and effect of H2-antagonists. Gastroenterology 88:1842–1851, 1985

    PubMed  Google Scholar 

  15. Merki HS: The intragastric long-term pH-metry (Die intragastrale Langzeit pH-Metrie—Methode und klinische Bedeutung). Dtsch Med Wochenschr 113:1443–1445, 1988

    PubMed  Google Scholar 

  16. Holm SA: A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70, 1979

    Google Scholar 

  17. Röhmel J, Merki HS, Wilder-Smith CH, Walt RP: Analysis and statistical evaluation of continuous pH recordings. Dig Dis 8(suppl 1):87–96, 1990

    PubMed  Google Scholar 

  18. Andersen J, Ström M, Naesdal J, Leire K, Walan A: Intravenous omeprazole: Effect of a loading dose on 24-hr intragastric pH. Aliment Pharmacol Ther 4:65–72, 1990

    Google Scholar 

  19. Baak L, Jansen J, Lamers C: Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids. Dig Dis Sci 35:596–602, 1990

    PubMed  Google Scholar 

  20. Walt RP, Reynolds JR, Langman MJS, Smart HL, Kitchingman G, Somerville KW, Hawkey CJ: Intravenous omeprazole rapidly raises intragastric pH. Gut 25:902–906, 1985

    Google Scholar 

  21. Lind T, Moore M, Olbe L: Intravenous omeprazole: Effect on 24-hour intragastric pH in duodenal ulcer patients. Digestion 34:78–86, 1986

    PubMed  Google Scholar 

  22. Shamburek RD, Schubert ML: Pharmacology of gastric acid inhibition. Baillere's Clin Gastroenterol 7:23–54, 1993

    Google Scholar 

  23. Cederberg C, Andersson T, Skanberg I: Omeprazole: Pharmacokinetics and metabolism in man. Scand J Gastroenterol 24(suppl 166):33–40, 1989

    PubMed  Google Scholar 

  24. Sackier JM, Halliday K, Sprott P, Coelho LGV, Batten JJ, Li SK, Sidebotham RL, Baron JH: The effect of intravenous omeprazole on 24h gastric secretion in healthy subjects. Comparisons of continuous and intermittent infusions: A pilot study. Eur J Gastroenterol Hepatol 3:679–684, 1991

    Google Scholar 

  25. Cederberg C, Bergstrand R: Continuous iv infusion of omeprazole effectively controls intragastric pH even during pentagastrin challenge. Gastroenterology 98:A29, 1990

    Google Scholar 

  26. Wilder Smith CH, Gwerder C, Hurlimann S, Merki HS: Dosing requirements during omeprazole infusions diminish with time: individually titrated and constant infusions of omeprazole over 48h. Gastroenterology 104:A223, 1993

    Google Scholar 

  27. Wilder-Smith CH, Merki HS: Antisecretory effects during prolonged infusions of omeprazole and tolerance to ranitidine. Gastroenterology 104:A224, 1993

    Google Scholar 

  28. Ballesteros MA, Hogan DL, Koss MA, Isenberg JI: Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost. Ann Intern Med 112:334–339, 1990

    PubMed  Google Scholar 

  29. Fiorucci S, Clausi GC, Farinelli M, Santucci L, Pelli MA, Morelli A: Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol 84:1416–1420, 1989

    PubMed  Google Scholar 

  30. Wilder-Smith CH, Merki HS: Tolerance during dosing with H2-receptor antagonists. Scand J Gastroenterol 27(suppl 193):14–19, 1992

    Google Scholar 

  31. Teyssen S, Joos A, Singer MV: Tolerance of intragastric acidity occurs within 7 days of a long-term therapy with the H2-receptor antagonist famotidine in healthy human subjects. Gastroenterology 104:A209, 1993

    Google Scholar 

  32. Teyssen S, Chari ST, Joos A, Singer MV: Effects of a 28-day therapy with famotidine on blood levels of alcohol and gastrin and intragastric pH in healthy human subjects. Scand J Gastroenterol 29:398–405, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Theodor-Kutzer Ufer, 68135, Mannheim, Germany

    S. Teyssen MD, S. T. Chari MD, DM, J. Scheid MD &  M. V. Singer MD

Authors
  1. S. Teyssen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. T. Chari MD, DM
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Scheid MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. V. Singer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr. Chari's Fellowship is supported by the Alexander von Humboldt Stiftung, Germany.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teyssen, S., Chari, S.T., Scheid, J. et al. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects. Digest Dis Sci 40, 247–255 (1995). https://doi.org/10.1007/BF02065405

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02065405

Key words

Search

Navigation